900+
Abcam employees worldwide
140+
PhD's within the company
12
Locations
globally
130
Countries delivered to worldwide
64%
Global researchers use Abcam products

Welcome to Abcam Investor
Relations

Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.

Our mission is to serve life scientists to help them achieve their mission faster by listening to their needs, continuously innovating and improving and by giving them the tools, data and experience they want. Our ambition is to become the most influential life science company for researchers worldwide.

We continue to identify the biological pathways of greatest interest to our consumers and continuously strive to provide products of the highest quality with increased specificity, reproducibility and sensitivity.  At the same time, through investment and acquisition, we are expanding into new markets, identifying new technologies and applications while moving into new geographic regions, thereby driving sustainable growth.

Headquartered in Cambridge, UK, we employ over 900 people across twelve locations serving researchers in more than 100 countries.

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +

We aspire to be the most influential life science company for researchers worldwide

Alan Hirzel
Chief Executive Officer

Abcam
Highlighted News

Interim Results delivering double digit sales growth

6th Mar 2017

– Revenue growth of 30.4% (10.0% constant currency)1 continued to exceed market growth – Maintain guidance of 9–11% constant currency revenue growth for full year Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science...

Read more +

Abcam commits to the lease of a new facility on the Cambridge Biomedical Campus

24th Oct 2016

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools announces that it has committed to the lease of a new facility for its global headquarters at the expanding Biomedical Campus in Cambridge,...

Read more +

Preliminary Results – Strong revenue performance enabling investment for future growth

12th Sep 2016

Abcam plc (“Abcam” or “the Company”, AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce its preliminary results for the year ended 30 June 2016. FINANCIAL HIGHLIGHTS Catalogue revenue increased by 17.4%...

Read more +